Nemaura Medical Inc. announced that it has retained Paul Kennedy as advisor for international growth opportunities member of the executive advisory board who will be advising the company on its commercial growth initiatives. Paul brings a wealth of Bio and Medtech experience with many years in the industry in different roles providing a well-rounded background. He spent 15 years at Novo Nordisk, including as CEO of the company in France. As a result of Paul’s years of experience in the biotech industry, he brings with him a large network that will be invaluable in helping the company in driving its commercial growth initiatives.